-
The Social Distribution of Quality Adjusted Life Expectancy (QALE) Among Deprivation Subgroups in China
Mar 10, 2025, 14:00 PM -
Prospective, Comparative Study Between Fully-Automated and Semi-Automated Whole Blood Processing Systems in a Colombian Blood Bank Center
Mar 10, 2025, 14:00 PM -
Patient-Reported Symptoms and Quality of Life: A Real-World Survey of Patients With Muscle Invasive Bladder Cancer
Mar 10, 2025, 14:00 PM -
Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses
Mar 10, 2025, 14:00 PM -
Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States
Mar 10, 2025, 14:00 PM -
Leveraging Machine Learning to Assess the Association of Rash and Survival in Patients With Advanced NSCLC
Mar 10, 2025, 14:00 PM -
Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database
Mar 10, 2025, 14:00 PM -
Is Poor Adherence to Good Modeling Practices Making Us Worry Too Much About Effect Modifiers? A Case Study in Moderate to Severe Plaque Psoriasis
Mar 10, 2025, 14:00 PM -
Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021
Mar 10, 2025, 14:00 PM -
Analysis of Disease Progression in 769 Patients With Dominant Alport Syndrome
Mar 10, 2025, 14:00 PM -
What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Mar 10, 2025, 14:00 PM -
Evaluation of a Novel Approach to Deduplication of Trial Registry Records in Systematic Reviews
Mar 10, 2025, 14:00 PM -
A Contemporary Analysis of Utilization, Clinical Outcomes and Costs of Robotic-Assisted, Laparoscopic, and Open Partial Nephrectomy Using the National Inpatient Sample
Mar 10, 2025, 14:00 PM -
The Cost Burden of Infertility Therapy for Women with a History of Hysteroscopic Adhesiolysis Compared to Those with Other or no Previous Intrauterine Surgery
Mar 10, 2025, 14:00 PM -
The Cost-Effectiveness of Eteplirsen vs. Standard of Care in Delaying the Progression of Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Seasonal Variation in Incidence and Outcomes of Hospitalizations with Severe Community-Acquired Bacterial Pneumonia in the U.S., 2018-2022
Mar 10, 2025, 14:00 PM -
Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study
Mar 10, 2025, 14:00 PM -
Clinical Effectiveness and Safety of Reference and Biosimilar G-CSF As Primary Prophylaxis in DLBCL
Mar 10, 2025, 14:00 PM
